PAST EVENT: ACTA Summit 2016

ACTA CMYK

 

Kit Haselden Photography - www.kithaselden.comKit Haselden Photography - www.kithaselden.comKit Haselden Photography - www.kithaselden.comKit Haselden Photography - www.kithaselden.com Kit Haselden Photography - www.kithaselden.comKit Haselden Photography - www.kithaselden.com Kit Haselden Photography - www.kithaselden.comKit Haselden Photography - www.kithaselden.com Kit Haselden Photography - www.kithaselden.comKit Haselden Photography - www.kithaselden.com

                       

 

ACTA SUMMIT 2016 PROGRAM

Morning Program: Understanding the impact of investigator-initiated clinical trials and registries

Session 1. Is quality cost effective? 

Chair: Prof John Zalcberg OAM

Opening Address
Prof John Zalcberg OAM:
Head, Cancer Research Program, School of Public Health & Preventive Medicine, Monash University

The new world order…welcome to the era of outcomes and value
Dr Neil Soderlund: Founder & Managing Director, Health Outcomes Australia

Health system sustainability and continuous self-improvement
Mr Mark Cormack: Deputy Secretary, Australian Dept. of Health

What we know about the health and economic benefit of trials and registries in Australia
Dr Robert Herkes: Clinical Director, Australian Commission on Safety & Quality in Health Care

What we don't know about the health and economic  benefit of trials and registries in Australia
Prof Steve Webb: Senior Staff Specialist, Intensive Care Unit, Royal Perth Hospital

Session 2. How do we measure impact on quality and cost?

Chair: Dr Tanya Pelly: Head of Clinical Integration, Health Outcomes Australia – download bio

The Health Consumers Perspective: Now and in the next 5 years
Ms Anne McKenzie AM: Consumer Advocate / Manager, Consumer & Community Health Research Network, WA

The Clinician Researcher's Perspective: Measuring impact on individual clinical practice
Prof Paul Myles: Director of Anaesthesia and Perioperative Medicine, Alfred Hospital 

The Health Service Provider's Perspective: How should we measure impact on service delivery?
Dr Peter Maclsaac: Clinical Research Informatics Fellow, Hunter Medical Research Institute

The Global Perspective: Measuring the impact of Australian-led trials & registries internationally
Prof Julie Bernhardt: Head, Stroke Division, The Florey Institute for Neruoscience and Mental Health 

Novel approaches to healthcare effectiveness research outside Australia
Prof Ben Mol: Professor of Obstetrics and Gynaecology, University of Adelaide

 

Afternoon Program: Maximising the impact of investigator-initiated clinical trials and registries

Session 3. Improving quality 

Chair: Dr Katie Groom: Senior Lecturer Department of Obstetrics & Gynaecology, University of Auckland – download bio

Health system benefits from improved performance
Mr George Savvides: Partner, Sodia / Former Managing Director and CEO, Medibank Private

How can clinical trials networks drive better translation or evidence into better quality care?

- Lessons from the PPROMT Trial (ACTA Trial of yhr Year 2016)
Prof Jonathan Morris AM: Director, Kolling Institute for Medical Research

- Lessons from trials in traumatic brain injury
Dr Dashiell Gantner: Intensive Care Consultant, Alfred Hospital

- Lessons from trials in paediatric haematology/oncology
Prof Catherine Cole: Stan Perron Chair of Paediatric Haematology & Oncology, School of Paediatrics & Child Health, University of Western Australia

How can registries drive better translation of real world data into better quality care?

- Lessons from the Prostate Cancer Outcomes Registry
Assoc Prof Sue Evans: Head, Clinical Registry Unit, School of Public Health & Preventive Medicine, Monash University

- Lessons from the Australian Orthopaedic Association National Joint Replacement Registry
Prof Stephen Graves: Director, Australian Orthopaedic Association National Joint Replacement Registry

 

Session 4. Improving cost effectiveness 

Chair: Prof Ben Mol

Strategies for supporting more trials of high value
Prof John Simes: Director, NHMRC Clinical Trials Centre

Clinical Quality Registries: A national approach
Mr Graeme Barden: Acting First Assistant Secretary, Research, Data & Evaluation Division, Australian Dept. of Health

Opportunities for linking evidence development to reimbursement in Australia
Prof Paul Glasziou: Director, Centre for Research in Evidence-Based Practice, Bond University

Unlocking the potential of administrative data
Dr Merran Smith: CEO, Population Health Research Network

 

Debate & panel discussion: "Quality Costs Money"

Dr Pradeep Philip: Founder & Managing Director, Ergo Consilium – download bio

Heather Wellington: Consultant, Clayton Utz – download bio

We're currently preparing a Summit proceedings report and will be available here shortly so please check back soon.

We'll also post a notice on twitter (@ACTACommunity) and via email to let delegates and ACTA members know when the report is available. 


SPONSORSHIP

 

Bb Jpeg Logo

 

 

 Proudly supported by Bellberry Limted, Major Partner for the ACTA Summit 2016.

 

 

ACTA_Communtiy_Sponsors

 

 

Thank you also to members of the ACTA community that have leant their support as Summit Partners. 

 

 

Australasian Gastrointestinal Trials Group (AGITG)

NHMRC Clinical Trials Centre (CTC)

South Australian Health and Medical Research Institute (SAHMRI)

 NHMRC Centre of Research Excellence in Cardiovascular Outcomes Improvement (CRE-COI)

 The Perinatal Society of Australia and New Zealand (PSANZ) Interdisciplinary Maternal Perinatal Australasian Collaborative Trials (IMPACT) Network

 Neuroscience Trials Australia

 


ORGANISING COMMITTEE

Professor Ben Mol (Convener)
The University of Adelaide

Dr Tanya Pelly
Head of Clinical Integration, Health Outcomes Australia

Prof John Simes
Deputy Director, NHMRC Clinical Trials Centre

Dr Neil Soderlund
Founder of Health Outcomes Australia 

Rhiannon Tate
ACTA Executive Officer

Prof Steve Webb
Immediate Past-Chair, Aust & NZ Intensive Care Society Clinical Trials Group

Jessica Weir
ACTA Administration Manager

Prof John Zalcberg OAM
Chair, Australasian Clinical Trials Alliance